Press release

Adamas to Present at Upcoming Healthcare Conferences

Sponsored by Businesswire

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, Chief Executive Officer, is scheduled to present at the following investor conferences:

  • 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24 at 1:40 p.m. ET (10:40 a.m. PT)
  • Cowen 41st Annual Healthcare Conference on Tuesday, March 2 at 2:50 p.m. ET (11:50 a.m. PT)
  • H.C. Wainwright Global Life Sciences Conference. Prerecorded presentation available starting on Tuesday, March 9 at 7:30 a.m. ET (4:30 a.m. PT)

The webcasts will be accessible on the investor relations section of the Adamas website at and will be available for 30 days.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit

Source: Adamas Pharmaceuticals, Inc.